Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 8:13 PM View:  | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 19-Nov-24 | Option Exercise | 30,554 | $6.00 | $183,324.00 | 171% 17.92K to 48.47K | |
| 16-Oct-24 4:40 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 15-Oct-24 | Option Exercise | 16,667 | $4.35 | $72,501.40 | 93% 17.92K to 34.59K | 4% |
| 16-Oct-24 4:40 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 15-Oct-24 | Planned Private Option Sale | 16,667 | $59.03 | $983,936.00 | (48%) 34.59K to 17.92K | |
| 16-Sep-24 7:36 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 16-Sep-24 | Option Exercise | 16,666 | $4.35 | $72,497.10 | 93% 17.92K to 34.59K | 4% |
| 16-Sep-24 7:36 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 16-Sep-24 | Planned Private Option Sale | 16,666 | $31.64 | $527,318.00 | (48%) 34.59K to 17.92K | |
| 13-Aug-24 6:01 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Option Exercise | 16,667 | $4.35 | $72,501.40 | 47% 35.84K to 52.51K | |
| 13-Aug-24 6:01 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Sale (Planned) | 100 | $34.73 | $3,472.76 | (< 1%) 35.94K to 35.84K | |
| 13-Aug-24 6:03 PM View: | Lind Kevin Robert CEO Director | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Option Exercise | 82,482 | $3.15 | $259,995.00 | 24% 348.45K to 430.93K | |
| 13-Aug-24 6:01 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 12-Aug-24 | Planned Option Sale | 16,567 | $34.73 | $575,332.00 | (32%) 52.51K to 35.94K | |
| 13-Aug-24 6:01 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 25-Jun-24 | Option Sale | 100 | $20.87 | $2,087.00 | (< 1%) 35.94K to 35.84K | |
| 09-Feb-24 4:11 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 08-Feb-24 | Grant | 17,920 | -- | -- | 100% 0 to 17.92K | |
| 09-Feb-24 4:10 PM View: | Roberts Brandi CFO | Longboard Pharmaceuticals, ... (LBPH) | 08-Feb-24 | Grant | 15,090 | -- | -- | 100% 0 to 15.09K | |
| 29-Jan-24 4:37 PM View: | Arena Pharmaceuticals Inc | Longboard Pharmaceuticals, ... (LBPH) | 25-Jan-24 | Private Sale | 3,978,540 | $24.25 | $96,479,600.00 | (100%) 3.98M to 0 | |
| 13-Aug-24 6:01 PM View: | Kaye Randall CMO | Longboard Pharmaceuticals, ... (LBPH) | 23-Jan-24 | Purchase | 100 | $24.82 | $2,482.00 | < 1% 35.84K to 35.94K | |
| 18-Mar-21 5:00 PM View: | Arena Pharmaceuticals Inc 10% Owner | Longboard Pharmaceuticals, ... (LBPH) | 16-Mar-21 | Conversion | 138,000 | -- | -- | 4% 3.84M to 3.98M |
